![Ben Wolozin](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Provenance du réseau au premier degré de Ben Wolozin
Entité | Type d'entité | Industrie | |
---|---|---|---|
Aquinnah Pharmaceuticals, Inc.
![]() Aquinnah Pharmaceuticals, Inc. BiotechnologyHealth Technology Aquinnah Pharmaceuticals, Inc. restores the health of people with ALS, Alzheimer?s disease and other neurodegenerative diseases. The company was founded by Glenn Larsen and Ben Wolozin in 2014 and is headquartered in Cambridge, MA.
5
| Holding Company | Biotechnology | 5 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Ben Wolozin via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Hydra Biosciences, Inc.
![]() Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Hydra Biosciences, Inc. develops pharmaceutical products. It is focused in major therapeutic areas, which include pain, inflammation, renal, anxiety, and pulmonary diseases. The company was founded by Laurie Bartlett Keating, Dean Y. Li, David E. Clapham, and Mark T. Keating in 2001 and is headquartered in Belmont, MA. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Endlyz Therapeutics, Inc.
![]() Endlyz Therapeutics, Inc. BiotechnologyHealth Technology Endlyz Therapeutics, Inc. is an American company that operates in the biotechnology industry. | Biotechnology | Director/Board Member | |
ARTham Therapeutics, Inc.
![]() ARTham Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Kaken Pharmaceutical Co., Ltd., ARTham Therapeutics, Inc. is a pharmaceutical company based in Yokohama, Japan. The Japanese company's mission is to deliver "medicines that matter" to improve patient health and contribute to enhanced quality of life through the development of innovative disease-modifying medicines. The company was founded by Sham Nikam, Naoto Uemura, and has been led by CEO Hiroshi Nagabukuro since 2018. ARTham Therapeutics was acquired by Kaken Pharmaceutical Co., Ltd. on December 13, 2021 for $111.95 million. | Pharmaceuticals: Major | Director/Board Member | |
Lanfear Advisors LLC | Corporate Officer/Principal | ||
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Takeda Pharmaceuticals International, Inc.
![]() Takeda Pharmaceuticals International, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Takeda Pharmaceutical Co., Ltd., Takeda Pharmaceuticals International, Inc. provides management consulting for pharmaceutical businesses. The company is based in Deerfield, IL. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
University of Washington
![]() University of Washington Other Consumer ServicesConsumer Services University of Washington functions as a College/University. The company is headquartered in Seattle, WA. | College/University | Masters Business Admin | |
University of Michigan | College/University | Graduate Degree | |
MOLECULAR TEMPLATES, INC. | Biotechnology | Director/Board Member | |
Arkuda Therapeutics, Inc.
![]() Arkuda Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Arkuda Therapeutics, Inc. engages in development of medicines to improve the lives of patients with neurological diseases. It leverages insights into progranulin and lysosomal biology to develop medicines to change the trajectory of neurodegenerative disease. The company was founded by Gerhard Koenig and Duane Burnett in 2018 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Founder | |
Penn State Research Foundation
![]() Penn State Research Foundation Miscellaneous Commercial ServicesCommercial Services Penn State Research Foundation provides scientific research services aimed at improving human conditions. The non-profit company is based in University Park, PA. | Miscellaneous Commercial Services | Director/Board Member | |
CAPTOR THERAPEUTICS SPOLKA AKCYJNA | Pharmaceuticals: Major | Director/Board Member | |
Dg Medicines
![]() Dg Medicines Pharmaceuticals: MajorHealth Technology Dg Medicines develops medicines and products in various therapeutic areas. | Pharmaceuticals: Major | Director/Board Member | |
Wyeth Pharmaceuticals LLC
![]() Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Accent Therapeutics, Inc.
![]() Accent Therapeutics, Inc. BiotechnologyHealth Technology Accent Therapeutics, Inc. operates as a biopharmaceutical company which develops treatments for cancer patients. The company was founded by Howard Y. Chang, Chuan He and Robert A. Copeland in September 2017 and is headquartered in Lexington, MA. | Biotechnology | Director/Board Member | |
Massachusetts Biomedical Initiatives | Director/Board Member | ||
Drexel University | College/University | Undergraduate Degree | |
Kojin Therapeutics, Inc.
![]() Kojin Therapeutics, Inc. BiotechnologyHealth Technology Kojin Therapeutics, Inc. operates as a small-molecule therapeutics company. It focuses on translating deep biological insight into the plasticity of human cell states to develop therapeutics for cancer, fibrosis, ischemia and immune modulation. The company was founded by Benjamin Cravatt, Stephanie K. Dougan and Stuart L.Schreiber and is headquartered in the United States. | Biotechnology | Director/Board Member | |
AbbVie Ventures LLC
![]() AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Investment Managers | Private Equity Investor | |
180 Therapeutics LP
![]() 180 Therapeutics LP Pharmaceuticals: MajorHealth Technology Part of 180 Life Sciences Corp., 180 Therapeutics LP engages in the development of biological therapies for the treatment of fibrosis. The company is based in Cambridge, MA. The company was founded by Glenn R. Larsen. | Pharmaceuticals: Major | Founder | |
Stony Brook University | College/University | Doctorate Degree | |
ANIKA THERAPEUTICS, INC. | Medical Specialties | Director/Board Member | |
Genetics Institute LLC
![]() Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member | |
Hibercell, Inc.
![]() Hibercell, Inc. Miscellaneous Commercial ServicesCommercial Services Hibercell, Inc. specializes on tumor dormancy detection and therapeutics. It provides treatment for primary tumors, metastatic cancer. The company was founded by Alan Rigby, Julio Aguirre-Ghiso, and Ari Nowacek and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chief Operating Officer |
Statistiques
Internationale
Etats-Unis | 25 |
Japon | 2 |
Pologne | 2 |
Sectorielle
Health Technology | 16 |
Consumer Services | 5 |
Commercial Services | 4 |
Finance | 2 |
Retail Trade | 2 |
Opérationnelle
Director/Board Member | 16 |
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 3 |
Founder | 3 |
Chief Operating Officer | 2 |
Relations les plus connectées
Insiders | |
---|---|
Charles Kunsch | 11 |
Jonathan Lanfear | 9 |
Glenn Larsen | 8 |
Duane Burnett | 2 |
Bob Carpenter | 1 |
- Bourse
- Insiders
- Ben Wolozin
- Connexions Sociétés